PP
RLAY icon

PDT Partners’s Relay Therapeutics RLAY Stock Holding History

PDT Partners’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,906
Closed -$245K – 591
2025
Q4 		$245K Sell
28,906
-24,731
-46% -$176K 0.02% 497
2025
Q3 		$280K Hold
53,637
– – 0.02% 519
2025
Q2 		$186K Hold
53,637
– – 0.01% 643
2025
Q1 		$141K Sell
53,637
-54,962
-51% -$215K 0.01% 705
2024
Q4 		$447K Sell
108,599
-18,673
-15% -$102K 0.04% 500
2024
Q3 		$901K Sell
127,272
-99,360
-44% -$742K 0.08% 386
2024
Q2 		$1.48M Buy
226,632
+73,641
+48% +$503K 0.14% 264
2024
Q1 		$1.27M Sell
152,991
-41,898
-21% -$409K 0.12% 284
2023
Q4 		$2.15M Buy
194,889
+54,040
+38% +$456K 0.24% 133
2023
Q3 		$1.18M Buy
140,849
+117,757
+510% +$1.27M 0.15% 237
2023
Q2 		$290K Buy
+23,092
New +$287K 0.04% 462
2022
Q4 		– Sell
-13,953
Closed -$312K – 855
2022
Q3 		$312K Sell
13,953
-99,198
-88% -$2.18M 0.05% 577
2022
Q2 		$1.9M Buy
113,151
+65,917
+140% +$1.41M 0.17% 187
2022
Q1 		$1.41M Sell
47,234
-22,866
-33% -$555K 0.12% 262
2021
Q4 		$2.15M Sell
70,100
-17,552
-20% -$555K 0.16% 221
2021
Q3 		$2.76M Buy
+87,652
New +$2.95M 0.2% 208

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PDT Partners's RLAY Position: Q1 2026 in Review

PDT Partners sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 28,906 shares — an estimated $245K sold.

PDT Partners first reported a position in RLAY in Q3 2021 and held it in 16 quarters. The position peaked at $2.76M in Q3 2021. 244 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • PDT Partners reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • PDT Partners sold 28,906 Relay Therapeutics shares in Q1 2026, an estimated $245K.
  • PDT Partners first reported a position in Relay Therapeutics in Q3 2021 and held it in 16 quarters.
  • PDT Partners's Relay Therapeutics position peaked at $2.76M in Q3 2021.
  • 244 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.